KLOW 80 mg Certificate of Analysis Batch APL-KLOW80-2609-04

KLOW 80 mg from batch APL-KLOW80-2609-04 was analysed on 19 September 2026 and measured 99.38% combined purity across GHK-Cu, KPV, TB-500 and BPC-157 by HPLC / Mass Spectrometry, passing all 5 release tests.

Combined purity: 99.38%
Components: GHK-Cu, KPV, TB-500, BPC-157
Result: All 5 tests passed
Tested: 19 September 2026
Method: HPLC / Mass Spectrometry
Net content: 80.14 mg

Independent verification

KLOW 80 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 99.40% purity by UPLC-MS/MS, analysed 27 August 2026 on lot APL-KLOW80-2608-01, net content GHK-Cu 51.38 mg, KPV 10.58 mg, BPC-157 10.44 mg, TB-500 10.58 mg, verification code OZ-HPLCMS-BJ29.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Third-Party Purity COA (PDF, opens in a new tab)99.40% purity by UPLC-MS/MS · net content GHK-Cu 51.38 mg, KPV 10.58 mg, BPC-157 10.44 mg, TB-500 10.58 mg Analysed 27 August 2026 Verification code OZ-HPLCMS-BJ29

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 1 of 5

Certificate of Analysis KLOW 80 mg Batch APL-KLOW80-2609-04

Compound Mix: KLOW
Lot Number: APL-KLOW80-2609-04
Analysis Date: 19 September 2026
Method: HPLC / Mass Spectrometry
Purity: 99.38%
Net Content: 80.14 mg

Net Content

GHK-Cu50.16 mg
KPV10.07 mg
TB-50010.13 mg
BPC-15710.03 mg

Form: Lyophilised Powder
Manufactured: September 2026
Issued: 19 September 2026
Document ID: APL-COA-KLOW80-2609-04
Verification Code: Batch traceable

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

4 components resolved on a single gradient and assigned by retention time against individually run reference standards. Purity is reported as their combined peak area; the remaining 4 integrated peaks are unassigned process impurities. Component share of total peak area reflects UV response at 214 nm, not the mass ratio in the vial.

Peak List

Peaks detected: 8

#	Time (min)	Area	% Area	Assignment
1	1.299	14,554	0.167	—
2	1.491	4,037,099	46.324	GHK-Cu
3	1.864	1,998,156	22.928	KPV
4	2.190	14,990	0.172	—
5	2.977	974,589	11.183	TB-500
6	3.269	1,651,041	18.945	BPC-157
7	3.757	16,645	0.191	—
8	5.100	7,843	0.090	—

Analytical Results

Test	Specification	Result	Status
Appearance	Blue/Blue-Green Lyophilised Powder	Conforms	PASS
Identity (MS)	All components confirmed	Confirmed	PASS
Purity (HPLC)	≥98.0% combined	99.38%	PASS
Total Peptide Content	95–105%	99.0%	PASS
Endotoxins	<0.5 EU/mg	<0.20 EU/mg	PASS

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 2 of 5

GHK-Cu

PubChem CID: 133697840 · CAS Number: 49557-75-7

Formula: C14H24CuN6O4 · MW: 403.92 g/mol · In this vial: 50.16 mg

SequenceGly-His-Lys

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 19 September 2026

Monitored (m/z)	Detected (m/z)	Relative Intensity
405	404.93	1.47
427	426.87	2.73

Detection assignment: GHK-Cu

Collected Mass Spectrum

Intensity ×10⁷

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 3 of 5

KPV

PubChem CID: 125672 · CAS Number: 67727-97-3

Formula: C16H30N4O4 · MW: 342.4 g/mol · In this vial: 10.07 mg

SequenceLys-Pro-Val

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 19 September 2026

Monitored (m/z)	Detected (m/z)	Relative Intensity
343	342.98	1.25
365	364.47	0.79

Detection assignment: KPV

Collected Mass Spectrum

Intensity ×10⁷

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 4 of 5

TB-500

PubChem CID: 16132341 · CAS Number: 77591-33-4

Formula: C212H350N56O78S · MW: 4963.4 g/mol · In this vial: 10.13 mg

SequenceAc-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES (43 aa, N-terminally acetylated)

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 19 September 2026

Monitored (m/z)	Detected (m/z)	Relative Intensity
828	828.52	0.71
994	993.92	1.55
1242	1242.1	0.74

Detection assignment: TB-500

Collected Mass Spectrum

Intensity ×10⁷

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 5 of 5

BPC-157

PubChem CID: 9941957 · CAS Number: 137525-51-0

Formula: C62H98N16O22 · MW: 1419.5 g/mol · In this vial: 10.03 mg

SequenceGEPPPGKPADDAGLV

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 19 September 2026

Monitored (m/z)	Detected (m/z)	Relative Intensity
474	473.86	0.5
711	710.97	1.48
1421	1421	0.35

Detection assignment: BPC-157

Collected Mass Spectrum

Intensity ×10⁷

Verification Protocol

Identity confirmed separately for each component by mass spectrometry against its own expected ion channels.
Purity measured by HPLC as the combined area of every assigned component peak against all integrated impurity peaks.
Batch traceability: this document reports the lot number printed on the vial.
Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.

View KLOW in the catalogue How to read this certificate